Intrinsic Value of S&P & Nasdaq Contact Us

SCYNEXIS, Inc. SCYX NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — SCYX

SCYNEXIS, Inc. (SCYX) has a market capitalization of $49.58M and trades at $1.11. The 52-week range is 0.565-1.31.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.5, Earnings Per Share (EPS) of $-0.17, annual revenue of $20.6M.

The stock has a beta of 1.15, operates in the Healthcare sector.

Trading Data
Current Price$1.11
52-Week Range0.565-1.31
Volume619.9K
Avg Volume (30D)614.18K
Market Cap$49.58M
Beta (1Y)1.15
Company
IPO Date2014-05-02
Employees28
CEODavid Gonzalez Angulo
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS8112922005
CUSIP811292200
Income (Latest Year)
Revenue$20.6M
Gross Profit$20.6M
EBITDA$-16.07M
Operating Income$-16.07M
Net Income$-8.61M
EPS$-0.17
EPS Diluted$-0.17
Shares Outstanding$49.93M
Balance Sheet (Latest Year)
Total Assets$59.03M
Current Assets$40.37M
Cash & ST Investments$21.26M
Total Liabilities$9.65M
Total Debt$2.18M
Net Debt$-19.08M
Total Equity$49.38M
Debt / Equity0.04
Valuation Ratios
P/E Ratio-6.5
P/S Ratio2.41
P/B Ratio1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message